Top topics and companies in Antibody Drug Conjugates

Antibodies: In our recent European Antibody Congress survey we asked which topics are the most important when it comes to the further development and advancement Antibody Drug Conjugates. The two most important points that were identified and that you want to learn more about are; Bottle necks in ADCs ADC clinical successes and failures   We also asked which companies …

Antibodies: Top pre-clinical and clinical ADC programs from Pfizer

#Antibodies: Do you agree that novel research concepts have the potential to transform ADC development? Dr Hans-Peter Gerber, now a Executive Director of BioConjugate Discovery and Development at Pfizer gave a review of how these novel research concepts for studying ADC targets, targeting vehicles, linkers and payloads could and perhaps are impacting this industry. Pre-clinical and clinical ADC programs Differences …